Congress needs to create a unified medical device and brand/generic drug system that does not draw arbitrary distinctions, upholds FDA authority in design and labeling, and preserves for consumers avenues to seek reasonable compensation for unwarranted harm.
May 02, 2013 at 04:04 AM
1 minute read
On March 19, the U.S. Supreme Court heard arguments in the fourth in a series of recent "pre-emption" cases involving prescription drugs and medical devices.
The issue raised in these cases is whether federal law pre-empts individuals from suing pharmaceutical companies or medical-device manufacturers under state law for defects in the design, or inadequacies in the labeling, of a drug or device approved by the U.S. Food and Drug Administration.
Presented by BigVoodoo
Join General Counsel and Senior Legal Leaders at the Premier Forum Designed For and by General Counsel from Fortune 1000 Companies
This conference brings together the industry's most influential & knowledgeable real estate executives from the net lease sector.
Join the industry's top owners, investors, developers, brokers & financiers at THE MULTIFAMILY EVENT OF THE YEAR!
Duane Morris LLP seeks a highly motivated junior associate to join its dynamic and growing Labor and Employment Class Action group in Chicag...
Duane Morris LLP seeks a full-time staff litigation attorney who has practiced between 3-5 years. Experience will include drafting motions, ...
Duane Morris LLP has an immediate opening for a senior level, highly motivated litigation associate to join its dynamic and growing Employme...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
